… . What did Neuren Pharmaceuticals management say? Neuren … from early in the second quarter. The powder formulation … offer Neuren ongoing revenue opportunities. Neuren Pharmaceuticals share price … 12 months, Neuren Pharmaceuticals shares have climbed 43% …

KIRKLAND, Wash., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a wearable medical device and digital healthcare company, today reported financial results for the second quarter fiscal 2026, which ended October 31, 2025 …

… , Corona Remedies is a pharmaceutical manufacturer with a diverse portfolio … the company posted a net profit of ₹46.19 crore for … year net profit of ₹149.43 crore in FY25. Revenue from … core operations reached ₹346.54 crore in the second quarter …

… bypassing restrictions, reducing export profits and pushing the economy to … will likely shift to more profitable fields. For instance, … .1 percent in the second quarter and only 0.6 … recorded in the engineering and pharmaceutical industries. The food industry, …

… oil & gas, and pharmaceuticals. Together, these five sectors … s share of their revenues form developed markets mostly … Outlook Notwithstanding the muted Q2, IT services sector showed … was reflective in second-quarter results. While revenue growth is likely …

… 2025 Predictions 1. Corporate Profit Margins Will Soar I expected … companies to squeeze more profit out of their operations … 2025 and 12% in the second quarter. Then in the third … proving my prediction right The pharma industry, as measured by the …

Here are 11 headlines to know on Dallas-based United Surgical Partners International, the ASC arm of Tenet Healthcare, as reported by Becker’s in 2025: The company reported third-quarter revenue of $1.28 billion, an 11.9% increase from the same period last …

… was reflective in second-quarter results. While revenue growth is … players, and specialty pharma with complex product pipelines … ), automobiles (EV and hybrids), pharma (Specialty / Complex Generics … Firms leveraging AI for revenue expansion are likely to …

… and fintech. The second quarter shows record export figures … exports during the second quarter was largely supported … , entry into high-revenue segments, and strengthening … smartphones, electronic components, pharmaceuticals, and electric mobility solutions …

… NYSE: DOCS) reported fiscal 2026 second quarter revenue of $168.5 million, … of Doximity. "In Q2, a record 650,000 … these outputs into draft pharmacokinetic reports in minutes rather … source of truth for pharmacokinetic and pharmacodynamic data across more …